As with the many other “most-favored-nation” deals between the White House and large pharmas, the agreement is short on ...

The Trump administration has finalized a deal with drugmaker AbbVie to cut the cost of certain medicines, marking the latest ...

Though far from the first large drugmaker to strike a pricing deal with the Trump administration, AbbVie’s new accord is ...

AbbVie strikes a Trump drug-pricing pact and a $5.6B cancer licensing deal, cutting U.S. prices while expanding its oncology ...

AbbVie is now one of 16 big pharma companies to sign MFN deals with the Trump administration and commit to the expansion of ...

AbbVie reached a deal with the Trump administration on drug prices in exchange for being exempted from tariffs and future ...

AbbVie on Tuesday announced a voluntary agreement with the Trump administration aimed at expanding access to medicines and lowering costs for US patients while preserving domestic pharmaceutical ...

AbbVie has reached a three-year agreement with the Trump administration to reduce drug costs and expand U.S. investment in pharmaceutical development. Under the deal, AbbVie will provide lower prices ...

AbbVie said on Monday that it has struck a three-year deal with U.S. President Donald Trump's administration to reduce drug prices, and has pledged $100 billion over the next decade for research and ...

Global life sciences leader AbbVie says it has entered into a voluntary agreement with the Trump administration to further ...